1-4 of 4
Steffen Doerfel
Close
Sort by
Journal Articles

Outcomes and Treatment Sequences of Therapies with BCL2- and BTK Inhibitors in Chronic Lymphocytic Leukemia (CLL): An Analysis of Patient Data within the German CLL Study Group (GCLLSG) Registry

Nadine Kutsch, Rudy Ligtvoet, Sandra Robrecht, Hartmut Linde, Thomas Illmer, Steffen Doerfel, Joerg Lipke, Ali Aldaoud, Rudolf Schlag, Jolanta Dengler, Othman Al-Sawaf, Petra Langerbeins, Paula Cramer, Barbara F. Eichhorst, Michael Hallek, Kirsten Fischer, Anna Maria Fink
Journal: Blood
Blood (2023) 142 (Supplement 1): 4644.
https://doi.org/10.1182/blood-2023-185741
Published: 2023
Journal Articles

Lenalidomide Maintenance after Front Line Therapy Substantially Prolongs Progression Free Survival in High Risk CLL: Interim Results of a Phase 3 Study (CLL M1 study of the German CLL Study Group)

Anna Maria Fink, MD, Jasmin Bahlo, PhD, Robrecht Sandra, PhD, Othman Al-Sawaf, MD, Ali Aldaoud, MD, Holger Hebart, MD, Kathleen Jentsch-Ulrich, MD, Steffen Doerfel, Dipl.MD, Kirsten Fischer, Clemens Martin Wendtner, MD, Thomas Noesslinger, MD, Paolo Ghia, MD PhD, Francesc Bosch, MD PhD, Arnon P. Kater, MD PhD, Karl-Anton Kreuzer, Hartmut Dohner, MD, Michael Kneba, Stephan Stilgenbauer, Sebastian Boettcher, MD, Barbara Eichhorst, MD, Michael Hallek, MD
Journal: Blood
Blood (2016) 128 (22): 229.
https://doi.org/10.1182/blood.V128.22.229.229
Published: 2016
Journal Articles

Multicenter Phase II Trial of Bendamustine, Lenalidomide and Dexamethasone (BRd) As 2 nd -Line Therapy for Multiple Myeloma

Ulrich JM Mey, Wolfram Brugger, MD, Mario Bargetzi, Heike Schwarb, MD, Andreas Schwarzer, MD, Tobias Dechow, MD, Paul Jehner, MD, Jacqueline Rauh, MD, Christian J. Taverna, MD, Mathias Schmid, MD, Martin Schmidt-Hieber, MD, Steffen Doerfel, Natalie Fischer, MD, Axel Ruefer, MD, Carsten Ziske, MD, Wolfgang Knauf, MD, Arnd Nusch, MD, Richard Cathomas, MD, Roger von Moos, MD, Elke Hiendlmeyer, Felicitas Hitz, MD, Christoph Driessen, MD
Journal: Blood
Blood (2014) 124 (21): 4779.
https://doi.org/10.1182/blood.V124.21.4779.4779
Published: 2014
Journal Articles

Effective and Safe Deferasirox Treatment of Patients with Various anemia's and Transfusional Iron-Overload in the Medical Practice: Results From Two German Observational Studies

Christian Junghanss, MD, Rudolf Schlag, MD, Bernd Gaede, MD, Matthias Moelle, MD, Steffen Doerfel, Frank Heits, MD, Ulrike Haus, PhD, Alexia Junkes, PhD, Oliver Leismann, PhD
Journal: Blood
Blood (2011) 118 (21): 5165.
https://doi.org/10.1182/blood.V118.21.5165.5165
Published: 2011